- Dr. Aditi Aggarwal is a radiation oncologist with an extensive experience of more than 10 years.
- She has received specialized training in advanced techniques such as IMRT, IGRT, SRS, SBRT, and SRT.
- She has been involved in various research projects at Tata Memorial Hospital and has special interest in Gynecological, Brain and Head Neck and Gastrointestinal Tumors and Sarcomas.
- She has worked at the best institutes of the country such as Tata Memorial Hospital, Mumbai, and AIIMS Hospital, Jhajjar.
- She is a member of institutions like Faculty National Cancer Institute, AIIMS, Senior Research Associate at MAMC and LNJP Hospital, Delhi, Associate Consultant at IOSPL, Fortis Noida, and Senior Resident at Tata Memorial Hospital.
Dr. Aditi Aggarwal
- Radiation Oncologist
- Senior Consultant Fellowship, MD, MBBS,10 years of experience
- Sanar International Hospital
- Gurgaon, India
Dr. Aditi Aggarwal
- Radiation Oncologist
- Senior Consultant Fellowship, MD, MBBS,10 years of experience
- Sanar International Hospital
- Gurgaon, India
Profile (Overview)
Specialities
Specialization
- Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) for Brain tumors Stereotactic Body
- Radiotherapy(SBRT) for Lung, Liver cancers, for Bone metastasis. Intensity Modulated Radiotherapy for Head & Neck, Breast, Gastrointestinal and Gynecological
- cancers and Sarcomas. Interstitial Brachytherapy for head neck, breast, Gynecological cancers and Sarcomas. Cancer Prevention especially for Breast and cervical cancers
Work Experience of Dr. Aditi Aggarwal
- Faculty National Cancer Institute, AIIMS
- MAMC and LNJP Hospital, Delhi
- Consultant, St Stephens Hospital
- Tata Memorial Hospital
Education
- Fellowship, Catalyst Clinical Sciences, Pune
- MD, VMMC and Safdarjang Hospital, Delhi (Delhi University)
- MBBS, Lady Hardinge Medical College, Delhi
Awards
- Young Investigator award by British Journal of Radiology (2014) Presentation at ASTRO 2012 at Boston, USA Research and Publications
Paper Published
- Comparitive study of efficacy, tolerability of four field box technique vs. two field anterior posterior technique in locally advanced carcinoma cervix: A prospective analysis.. Cancer Biology and Therapy. 05/2009; 8:9, 759-764.
- Clinical Outcome of Early-Stage Endometroid Adenocarcinoma: A Tertiary Cancer Center Experience. International Journal of Gynecological Cancer .10/2013; 23(8):1446-1452.
- Evaluation of Internal Target Volume in patients undergoing Image Guided Intensity Modulated adjuvant radiation for gastric cancers. British Journal of Radiology. 11/2013; 10/1259.
- Acute Toxicity And Compliance With Tomotherapy Based Adjuvant Intensity Modulated Radiotherapy In Patients With Gastric Cancer: Results From Prospective Study. Annals of Oncology. 2013; 24(4):iv63.
- IMRT is not superior to 3DCRT for adjuvant gastric cancer radiation: A matched pair analysis. JCRT.10/2015;11(3): 623-629.
- Impact of Oligodendroglial component in Glioblastoma (GBM-O): Is the outcome favourable than Glioblastoma?. Clinical Neurology and Neusosurgery. 8/2015; 135: 46-53.
- Antiemetic Trials in Oncology: What should be done next? Natl Med J India. 29(2).Mar-Apr 2016.
- Adaptive Radiotherapy: A hybrid (on-line image guidance + off-line adaptive) approach for head and neck cancer. Poster in ESTRO 2016
- Organization of Chemotherapy and Systemic Therapy Services in India: Devil lies in details. Journal of Global Oncology. 2017 ;3(2): 182-183.
- Discordance of histo-pathological diagnosis of patients with soft tissue sarcoma referred to tertiary care center. Journal of Clinical Oncology. 2017 35:15_suppl, 11064-11064.
- IlavarasiVanidassane et al Pazopanib toxicity in a metastatic sarcoma cohort : Are Indian patients different?. Annals of Oncology (2017) 28 (suppl_10): x149-x152. 10.1093/annonc/mdx675.
- Cardiovascular Disease Burden in Cancer Patients from 2003 to 2014. European Heart Journal – Quality of Care and Clinical Outcomes, 2017;4(1): 69–70.
- Fate of incidental gall bladder cancers: A single centre experience.,. E-poster presented at ICC 2017.
- Chemotherapy in non metastatic osteosarcoma: Recent advances and implication for developing countries. Journal of Global Oncology. 2018; 4: 1-5.
- Adding olanzapine to three drugs anti emetic regimen: Is it time to jump the gun? IJMPO 3/2018; 39 (2):125.
- IlavarasiVanidassaneGeddis Trial and Its Primary End PointThere is An Elephant in the Room! Clin Oncol. 2018; 3: 1414.
- Retrospective analysis of management and outcome of advanced soft tissue sarcomas (STS) with rare histology.. J Clin Oncol 36, 2018 (suppl; abstr e23564)
- Outcomes of advanced soft tissue sarcoma from dedicated medical oncology sarcoma clinic in North India and evaluation of the respective model. J Clin Oncol 36, 2018 (suppl; abstr e23561)
- The quest for histology driven neoadjuvant chemotherapy in soft tissue sarcoma: end of road or just the beginning? Epub ahead of Print.2018
- Advanced dermatofibrosarcoma protuberans treatment with imatinib – Experience from dedicated sarcoma medical oncology clinic in India . Accepted for publication in JGO June 2018
- Accepted in Indian Journal of Cancer
- Study of effects of Dwell Time Deviation Constraints on Inverse planning simulated annealing optimized plans of intracavitary brachytherapy of carcinoma cervix. JCRT. Epub ahead of print 2018
- Management of Gynaecological malignancies- A case based approach. Chapter in Textbook of Obstetrics and Gynaecology. A K Rathi, Aditi Aggarwal. 2018
Similar Doctors
